Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:55:49.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The government funding status notice has been removed; core trial information remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:13.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added sponsor attribution for H. Lee Moffitt Cancer Center and Research Institute and a link to the Moffitt Clinical Trials website under Helpful Links.
    Difference
    0.2%
    Check dated 2025-11-11T02:27:36.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Minor visual/layout refinements observed with no changes to core study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:10.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Updated release notes: version bumped to v3.2.0 and added a government-status notice; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T05:29:46.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:21.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.